Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
1(33%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
1
33%
Ph early_phase_1
2
67%

Phase Distribution

2

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
Early Phase 1First-in-human
2(66.7%)
N/ANon-phased studies
1(33.3%)

Highest Phase Reached

Early Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Completed(2)

Detailed Status

Completed2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
100.0%
Most Advanced
Early Phase 1

Trials by Phase

Early Phase 12 (66.7%)
N/A1 (33.3%)

Trials by Status

completed267%
recruiting133%

Recent Activity

1 active trials
Showing 3 of 3
recruitingearly_phase_1

Intradermal Influenza Vaccination

NCT06067555
completedearly_phase_1

A Pilot Study to Assess the Safety, PK and PD of Insulin Injected Via MicronJet or Conventional Needle

NCT00602914
completednot_applicable

A Study to Assess the Safety and Efficacy of a Microneedle Device for Local Anesthesia

NCT00539084

Clinical Trials (3)

Showing 3 of 3 trials
NCT06067555Early Phase 1

Intradermal Influenza Vaccination

Recruiting
NCT00602914Early Phase 1

A Pilot Study to Assess the Safety, PK and PD of Insulin Injected Via MicronJet or Conventional Needle

Completed
NCT00539084Not Applicable

A Study to Assess the Safety and Efficacy of a Microneedle Device for Local Anesthesia

Completed

All 3 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
3